Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Flückiger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Praxis|September 18, 2014
[Acute spondylodiscitis]Miriam Flückiger, Gustav Andreisek, Barbara Hasse
Therapeutische Umschau. Revue Therapeutique|October 27, 2021
[Investigations of Anorectal Function]Mark Fox, Konstantinos Markopoulos, Miriam Flückiger
Praxis|May 27, 2026
[Chronic diarrhea in Parkinson's disease during Levodopa therapy]Annina Macht, Gieri Cathomas, Eveline Bauer, et al.
Plos One|August 17, 2018
Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trialStefan Bilz, Miriam Flückiger, Fabian Meienberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Praxis|September 18, 2014
[Acute spondylodiscitis]Miriam Flückiger, Gustav Andreisek, Barbara Hasse
Therapeutische Umschau. Revue Therapeutique|October 27, 2021
[Investigations of Anorectal Function]Mark Fox, Konstantinos Markopoulos, Miriam Flückiger
Praxis|May 27, 2026
[Chronic diarrhea in Parkinson's disease during Levodopa therapy]Annina Macht, Gieri Cathomas, Eveline Bauer, et al.
Plos One|August 17, 2018
Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trialStefan Bilz, Miriam Flückiger, Fabian Meienberg, et al.
Pageof 1